Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience
- 5 February 2020
- journal article
- research article
- Published by Springer Nature in Child's Nervous System
- Vol. 36 (5) , 941-949
Abstract
Posterior fossa ependymomas (PFE) are among the most frequently occurring solid tumors in children. Their definitive treatment is surgical excision and adjuvant radio-chemotherapy. This study aimed to investigate prognostic effects of age, H3K27me3 status, extent of resection, radiation treatment (RT), Ki67 index, WHO grade, and ATRX and H3K27M mutations in PFE patients.Keywords
This publication has 41 references indexed in Scilit:
- Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa EpendymomaCancer Cell, 2011
- Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsJournal of Negative Results in BioMedicine, 2011
- Pediatric Ependymoma: Biological PerspectivesMolecular Cancer Research, 2009
- The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factorsLaboratory Investigation, 2008
- Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescuePediatric Blood & Cancer, 2007
- Stem cells of ependymomaBritish Journal of Cancer, 2006
- Is gross-total resection sufficient treatment for posterior fossa ependymomas?Journal of Neurosurgery, 2005
- Ki‐67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomasNeuropathology and Applied Neurobiology, 1998
- Volume of Pituitary MacroadenomasJournal of Computer Assisted Tomography, 1992
- The prognostic significance of postoperative residual tumor in ependymomaNeurosurgery, 1991